摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5,5-trimethyl-2-<2'-<4''-(carboxymethyl)-1''(R)-methyl-3''-<(trimethylsilyl)methylene>cyclohex-2''-yl>ethyl>-1,3-dioxane | 116399-92-9

中文名称
——
中文别名
——
英文名称
2,5,5-trimethyl-2-<2'-<4''-(carboxymethyl)-1''(R)-methyl-3''-<(trimethylsilyl)methylene>cyclohex-2''-yl>ethyl>-1,3-dioxane
英文别名
2,5,5-trimethyl-2-(2'-{4''-(carboxymethyl)-1''(R)-methyl-3''-[(trimethylsilyl)methylene]cyclohex-2''-yl}ethyl)-1,3-dioxane;2-[(1S,2Z,3S,4R)-4-methyl-3-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]-2-(trimethylsilylmethylidene)cyclohexyl]acetic acid
2,5,5-trimethyl-2-<2'-<4''-(carboxymethyl)-1''(R)-methyl-3''-<(trimethylsilyl)methylene>cyclohex-2''-yl>ethyl>-1,3-dioxane化学式
CAS
116399-92-9
化学式
C22H40O4Si
mdl
——
分子量
396.643
InChiKey
GGZCGCFRYXRMFC-UWTLDHTDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    473.0±20.0 °C(Predicted)
  • 密度:
    0.982±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Stereoselective total synthesis of (+)-artemisinin, the antimalarial constituent of Artemisia annua L
    摘要:
    A 10-step stereoselective total synthesis of the antimalarial cadinane sesquiterpene (+)-artemisinin (1) is described. Elaboration of (R)-(+)-pulegone to the known sulfoxide 11 was followed by dianion alkylation and desulfurization to provide the trans-2,3-substituted cyclohexanone 7. Homologation to the cyclohexenecarboxaldehyde 6 was followed by a diastereoselective silyl anion addition to afford the silyl acetate 15. Tandem Claisen ester-enolate rearrangement and dianion alkylation furnished the fully functionalized vinylsilane 18 that underwent abnormal ozonolysis and cyclization to provide the natural product 1.
    DOI:
    10.1021/ja00029a028
  • 作为产物:
    描述:
    2,5,5-trimethyl-2-<2'-<1''R-methyl-3''-<(trimethylsilyl)hydroxymethyl>cyclohex-3''-en-2''-yl>ethyl>-1,3-dioxane acetyl ester 在 正丁基锂二乙胺 作用下, 以 四氢呋喃正己烷 为溶剂, 以63%的产率得到2,5,5-trimethyl-2-<2'-<4''-(carboxymethyl)-1''(R)-methyl-3''-<(trimethylsilyl)methylene>cyclohex-2''-yl>ethyl>-1,3-dioxane
    参考文献:
    名称:
    Stereoselective total synthesis of (+)-artemisinin, the antimalarial constituent of Artemisia annua L
    摘要:
    A 10-step stereoselective total synthesis of the antimalarial cadinane sesquiterpene (+)-artemisinin (1) is described. Elaboration of (R)-(+)-pulegone to the known sulfoxide 11 was followed by dianion alkylation and desulfurization to provide the trans-2,3-substituted cyclohexanone 7. Homologation to the cyclohexenecarboxaldehyde 6 was followed by a diastereoselective silyl anion addition to afford the silyl acetate 15. Tandem Claisen ester-enolate rearrangement and dianion alkylation furnished the fully functionalized vinylsilane 18 that underwent abnormal ozonolysis and cyclization to provide the natural product 1.
    DOI:
    10.1021/ja00029a028
点击查看最新优质反应信息

文献信息

  • Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin
    作者:Mitchell A. Avery、Fenglan Gao、Wesley K. M. Chong、Sanjiv Mehrotra、Wilbur K. Milhous
    DOI:10.1021/jm00078a017
    日期:1993.12
    series of C-9 beta-substituted artemisinin analogs (2-21) were synthesized via dianion alkylation of the total synthetic intermediate 57 followed by subsequent ozonolysis/acidification, or by alkylation of the enolate derived from (+)-9-desmethylartemisinin, 2. Inactive acyclic analogs 22 and 23 were synthesized by nucleophilic epoxide opening and the ring contracted analog 24 was prepared by an alternate
    一系列 C-9 β 取代的青蒿素类似物 (2-21) 是通过总合成中间体 57 的二价阴离子烷基化合成的,随后进行臭氧分解/酸化,或通过从 (+)-9-去甲基青蒿素衍生的烯醇化物的烷基化, 2.通过亲核环氧化物开环合成无活性无环类似物22和23,通过替代路线制备环收缩类似物24。10-Deoxo-9-烷基衍生物68和70是从制备9-烷基衍生物的中间体集中合成的。在抗药性恶性疟原虫的 W-2 和 D-6 克隆中进行体外生物测定。9-烷基内酯衍生物的比较分子场分析 (CoMFA) 提供了一个具有交叉验证 r2 = 0.793 的模型。包含无活性的 1-脱氧青蒿素类似物 26-42 提供了一个值为 0.857 的模型。使用 CoMFA 模型以良好的准确性预测了许多其他不同结构的类似物 (43-56) 的活性。
  • Structure−Activity Relationships of the Antimalarial Agent Artemisinin. 5. Analogs of 10-Deoxoartemisinin Substituted at C-3 and C-9
    作者:Mitchell A. Avery、Sanjiv Mehrotra、Theresa L. Johnson、Jason D. Bonk、Jeffrey A. Vroman、Robert Miller
    DOI:10.1021/jm9603577
    日期:1996.1.1
    the presence of triethylsilane. In this manner, 10-deoxoartemisinin (3) could be obtained from artemisinin (1) in greater than 95% overall yield. All analogs were tested in vitro against W-2 and D-6 strains of Plasmodium falciparum. Several of the analogs were much more active than the natural product (+)-artemisinin (1) or 10-deoxoartemisinin (3). Conventional structure-activity relationships are discussed
    10-脱氧青蒿素 3 的新型 3-和 9-取代类似物 (4-19) 是从相应的已知内酯通过硼氢化钠和三氟化硼乙醚合一锅还原制备的。在小规模反应中遇到了与这种非均相反应相关的重现性问题,因此寻求替代方法来减少这种反应。使用两步序列,包括用二异丁基氢化铝低温还原,然后在三乙基硅烷的存在下用三氟化硼醚合物脱氧,通过相应的中间体内酯将内酯转化为四氢吡喃的重现性更高。以这种方式,10-脱氧青蒿素(3)可以从青蒿素(1)中获得,总产率超过 95%。所有类似物都针对恶性疟原虫的 W-2 和 D-6 菌株进行了体外测试。一些类似物比天然产物 (+)-青蒿素 (1) 或 10-脱氧青蒿素 (3) 更具活性。讨论了与生物测定数据相关的常规构效关系。
  • Avery; Bonk; Chong, Journal of Medicinal Chemistry, 1995, vol. 38, # 26, p. 5038 - 5044
    作者:Avery、Bonk、Chong、Mehrotra、Miller、Milhous、Goins、Venkatesan、Wyandt、Khan、Avery
    DOI:——
    日期:——
  • Radiolabeled antimalarials: Synthesis of 14C-artemisinin
    作者:Mitchell A. Avery、Jason D. Bonk、James Bupp
    DOI:10.1002/(sici)1099-1344(199603)38:3<263::aid-jlcr839>3.0.co;2-o
    日期:1996.3
    The stereoselective total synthesis of the antimalarial agent C-14-(+)-artemisinin (1), incorporating C-14 at C-16 (C-9 methyl) is reported, in 18% radiochemical yield from acid 3.
  • The Total synthesis of (+)-artemisinin and (+)-9-desmethyltemesinin
    作者:Mitchell A. Avery、Clive Jennings-White、Wesley K.M. Chong
    DOI:10.1016/s0040-4039(00)96582-1
    日期:1987.1
查看更多